Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
27.00    0.20 (0.75%)
Bid:
25.60
Ask:
26.70
Spread: 1.10 (4.297%)
Market Cap: £116.17m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

AGM Statement

15 May 2006 10:26

Immediate Release: 15 May 2006 International Brand Licensing plc ("IBL" or the "Company") AGM Statement At today's AGM, Chairman Adam Reynolds commented:"In my statement of 19th April 2006, I was pleased to report a substantialturnaround in the Company's fortunes by producing a full year profit for thefirst time in the Company's history.I am now delighted to announce to you that the current year has startedextremely well with the first four month's sales being around 25% higher thanthe corresponding period last year, which in itself was a record year. Inaddition, the Board is continuing to drive down fixed costs and is activelylooking at ways of increasing its gross margins through both manufacturing anddistribution efficiencies.It is both reassuring and rewarding that sales of the official England Admiralreplica kit are still outperforming all our expectations and that the Companyis further benefiting from its focus on cost savings since the Board wasrestructured last year.Last week, the Company announced the sale of its Admiral trademarks for theGreece and Cyprus territories for a cash consideration of ‚£775,000, reflectingthe increasing value of the Admiral brand globally. Whilst expanding thegeographical reach of the Admiral brand remains at the core of the Company'sstrategy, our over-riding aim is to maximise shareholder value which we firmlybelieve this transaction achieved.We are currently in discussion with several potential partners regarding thesigning of new long term license agreements in regions where we are currentlynot represented. We are confident that the number of territories in which theAdmiral brand is distributed, currently 22, can be substantially increased inthe medium to long term, ensuring continued strong growth in the business goingforward.Your Board is delighted with the progress the Company has made during the yearto date and we remain confident that we will continue to improve shareholdervalue throughout the year ahead."For Further information:Adam Reynolds/Paul FoulgerInternational Brand Licensing020 7823 1733ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20158:03 amRNSWithdrawal of non-binding proposal
25th Aug 20153:00 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
25th Aug 20152:58 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
25th Aug 20152:36 pmBUSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20152:15 pmRNSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20151:10 pmRNSHolding(s) in Company
25th Aug 201511:54 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 201511:30 amBUSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 201510:52 amRNSHolding(s) in Company
24th Aug 201511:19 amRNSForm 8.3 - EKF Diagnostics Holdings Plc
24th Aug 20157:01 amRNSAnnouncement under rule 2.4 of the Takeover Code
24th Aug 20157:00 amRNSFurther non-binding proposal
18th Aug 201512:00 pmRNSConclusion of Strategic Review
18th Aug 201511:55 amRNSTrading update
10th Aug 20159:25 amRNSHolding(s) in Company
19th May 20152:26 pmRNSResult of AGM
13th May 20157:00 amRNSLaunch of PrecisionPath Colon
1st May 20153:15 pmRNSPosting of Annual Report & Notice of AGM
24th Apr 20154:44 pmRNSHolding(s) in Company
21st Apr 20151:17 pmRNSData for PointMan Technology presented at AACR
8th Apr 201511:41 amRNSHolding(s) in Company
8th Apr 201511:36 amRNSHolding(s) in Company
2nd Apr 20157:00 amRNSShareholder update
26th Mar 20153:47 pmRNSHolding(s) in Company
25th Mar 20153:05 pmRNSHolding(s) in Company
19th Mar 20159:40 amRNSHolding(s) in Company
18th Mar 20153:41 pmRNSHolding(s) in Company
16th Mar 20157:00 amRNSFinal Results
2nd Mar 20157:00 amRNSCollaboration to improve colon cancer treatment
23rd Feb 20157:00 amRNSNotice of results & investor results presentation
2nd Feb 20157:00 amRNSChange of Adviser
28th Jan 20157:00 amRNSTrading update
23rd Jan 20157:00 amRNSCorporate Collaboration
23rd Jan 20157:00 amRNSPointMan collaboration with ANGLE plc
5th Jan 20157:00 amRNSPayment of DiaSpect's deferred consideration
17th Dec 20147:00 amRNSTrading update & potential Board appointment
11th Nov 20144:46 pmRNSHolding(s) in Company
1st Oct 201411:36 amRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSUS collaboration to develop blood tests for cancer
15th Sep 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSDirectorate Change
13th Aug 20147:00 amRNSNotice of results and investor briefing
23rd Jul 20147:00 amRNSTrading update
8th Jul 20147:00 amRNSContract Win and Regulatory Approval
13th Jun 201412:53 pmRNSHolding(s) in Company
9th Jun 20145:59 pmRNSGrant of Share Options
6th Jun 20142:46 pmRNSHolding(s) in Company
2nd Jun 20144:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.